Paraneoplastic pemphigus

Journal of Dermatology

Volumn 34, Issue 8, 2007, Pages 503-511

  Zhu, Xuejun ^a   Zhang, Bingxin ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Associated tumor; Autoantibody; Paraneoplastic pemphigus; Removal tumor

Indexed keywords

ANTIGEN; AUTOANTIBODY; BULLOUS PEMPHIGOID ANTIGEN 1; DESMOGLEIN; DESMOGLEIN 1; DESMOGLEIN 3; DESMOPLAKIN; ENVOPLAKIN; IMMUNOGLOBULIN; PERIPLAKIN; PLAKIN;

ACANTHOLYSIS; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; AUTOIMMUNE DISEASE; BLISTER; BLOOD ANALYSIS; BRONCHIOLITIS OBLITERANS; CELL DEATH; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; DEATH; FOLLICULAR DENDRITIC CELL; HISTOPATHOLOGY; HUMAN; KERATINOCYTE; LYMPHOPROLIFERATIVE DISEASE; NONHODGKIN LYMPHOMA; PARANEOPLASTIC PEMPHIGUS; PEMPHIGUS; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN FAMILY; RESPIRATORY FAILURE; RESPIRATORY SYSTEM; REVIEW; SKIN DEFECT; SKIN DISEASE; THYMOMA; TUMOR DIAGNOSIS;

ADOLESCENT; ADULT; AUTOANTIBODIES; BRONCHIOLITIS OBLITERANS; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; MOUTH MUCOSA; PARANEOPLASTIC SYNDROMES; PEMPHIGUS; SKIN;

EID: 34547757415     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2007.00322.x     Document Type: Review

References (93)

1. Anhalt GJ, Kim SC, Stanley JR et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990 323 : 1729 1735.
2. Camisa C, Helm TN. Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease. Arch Dermatol 1993 129 : 883 886.
3. Kaplan I, Hodak E, Ackerman L et al. Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations. Oral Oncol 2004 40 : 553 562.
4. Wang L, Bu D, Yang Y et al. Castleman's tumours and production of autoantibody in paraneoplastic pemphigus. Lancet 2004 363 : 525 531.
5. Wang J, Bu DF, Li T et al. Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus. Br J Dermatol 2005 153 : 558 564.
6. Zhang B, Zheng R, Wang J et al. Epitopes in the linker subdomain region of envoplakin recognized by autoantibodies in paraneoplastic pemphigus patients. J Invest Dermatol 2006 126 : 832 840.
7. Wang J, Zhu X, Li R et al. Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China. Arch Dermatol 2005 141 : 1285 1293.
8. Nguyen VT, Ndoye A, Bassler KD et al. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol 2001 137 : 193 206.
9. Chin AC, Stich D, White FV et al. Paraneoplastic pemphigus and bronchiolitis obliterans associated with a mediastinal mass: A rare case of Castleman's disease with respiratory failure requiring lung transplantation. J Pediatr Surg 2001 36 : E22.
10. Inaoki M, Kodera M, Fujimoto A et al. Paraneoplastic pemphigus without antidesmoglein 3 or antidesmoglein 1 autoantibodies. Br J Dermatol 2001 144 : 610 613.
11. Hsiao CJ, Hsu MM, Lee JY et al. Paraneoplastic pemphigus in association with a retroperitoneal Castleman's disease presenting with a lichen planus pemphigoides-like eruption. A case report and review of literature. Br J Dermatol 2001 144 : 372 376.
12. Marzano AV, Grammatica A, Cozzani E et al. Paraneoplastic pemphigus. A report of two cases associated with chronic B-cell lymphocytic leukaemia. Br J Dermatol 2001 145 : 127 131.
13. Rivollier C, Vaillant L, Machet MC et al. Paraneoplastic pemphigus: a pustular form during chronic lymphoid leukemia. Ann Dermatol Venereol 2001 128 : 644 648.
14. Horn TD, Anhalt GJ. Histologic features of paraneoplastic pemphigus. Arch Dermatol 1992 128 : 1091 1095.
15. Anhalt GJ. Paraneoplastic pemphigus. J Investig Dermatol Symp Proc 2004 9 : 29 33.
16. Fullerton SH, Woodley DT, Smoller BR et al. Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation. Jama 1992 267 : 1500 1502.
17. Camisa C, Helm TN, Liu YC et al. Paraneoplastic pemphigus: a report of three cases including one long-term survivor. J Am Acad Dermatol 1992 27 : 547 553.
18. Hashimoto T, Amagai M, Watanabe K et al. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 1995 104 : 829 834.
19. Oursler JR, Labib RS, Ariss-Abdo L et al. Human autoantibodies against desmoplakins in paraneoplastic pemphigus. J Clin Invest 1992 89 : 1775 1782.
20. Kim SC, Kwon YD, Lee IJ et al. cDNA cloning of the 210-kDa paraneoplastic pemphigus antigen reveals that envoplakin is a component of the antigen complex. J Invest Dermatol 1997 109 : 365 369.
21. Kiyokawa C, Ruhrberg C, Nie Z et al. Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex. J Invest Dermatol 1998 111 : 1236 1238.
22. Amagai M, Nishikawa T, Nousari HC et al. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest 1998 102 : 775 782.
23. Borradori L, Trueb RM, Jaunin F et al. Autoantibodies from a patient with paraneoplastic pemphigus bind periplakin, a novel member of the plakin family. J Invest Dermatol 1998 111 : 338 340.
24. Rybojad M, Leblanc T, Flageul B et al. Paraneoplastic pemphigus in a child with a T-cell lymphoblastic lymphoma. Br J Dermatol 1993 128 : 418 422.
25. Joly P, Richard C, Gilbert D et al. Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 2000 43 : 619 626.
26. Mimouni D, Anhalt GJ, Lazarova Z et al. Paraneoplastic pemphigus in children and adolescents. Br J Dermatol 2002 147 : 725 732.
27. Nikolskaia OV, Nousari CH, Anhalt GJ. Paraneoplastic pemphigus in association with Castleman's disease. Br J Dermatol 2003 149 : 1143 1151.
28. Bialy-Golan A, Brenner S, Anhalt GJ. Paraneoplastic pemphigus: oral involvement as the sole manifestation. Acta Derm Venereol 1996 76 : 253 254.
29. Fried R, Lynfield Y, Vitale P et al. Paraneoplastic pemphigus appearing as bullous pemphigoid-like eruption after palliative radiation therapy. J Am Acad Dermatol 1993 29 : 815 817.
30. Joly P, Thomine E, Gilbert D et al. Overlapping distribution of autoantibody specificities in paraneoplastic pemphigus and pemphigus vulgaris. J Invest Dermatol 1994 103 : 65 72.
31. Lotem M, Trattner A, Ingber A. Paraneoplastic pemphigus: reevaluation of a case from the past. Arch Dermatol 1994 130 : 1454.
32. Bowen GM, Peters NT, Fivenson DP et al. Lichenoid dermatitis in paraneoplastic pemphigus: a pathogenic trigger of epitope spreading? Arch Dermatol 2000 136 : 652 656.
33. Borradori L, Lombardi T, Samson J et al. Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus. Arch Dermatol 2001 137 : 269 272.
34. Heizmann M, Itin P, Wernli M et al. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL. Am J Hematol 2001 66 : 142 144.
35. Tilakaratne W, Dissanayake M. Paraneoplastic pemphigus: a case report and review of literature. Oral Dis 2005 11 : 326 329.
36. Martinez De Pablo MI, Iranzo P, Mascaro JM et al. Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone. Acta Derm Venereol 2005 85 : 233 235.
37. Vun YY, Lun K, Strutton G. Use of biosynthetic dressings in paraneoplastic pemphigus. Australas J Dermatol 2004 45 : 133 135.
38. Rossum MM, Verhaegen NT, Jonkman MF et al. Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalities. Leuk Lymphoma 2004 45 : 2327 2332.
39. Stark GL, Goff DK, Spickett GP et al. Paraneoplastic pemphigus occuring after radiotherapy for relapsed non-Hodgkin's lymphoma in a patient with common variable immunodeficiency. Hematol J 2003 4 : 154 158.
40. Joly P, Gilbert D, Thomine E et al. Immunofluorescence and immunoelectron microscopy analyses of a human monoclonal anti-epithelial cell surface antibody that recognizes a 185-kD polypeptide: a component of the paraneoplastic pemphigus antigen complex? J Invest Dermatol 1993 101 : 339 345.
41. Izaki S, Yoshizawa Y, Kitamura K et al. Paraneoplastic pemphigus: potential therapeutic effect of plasmapheresis. Br J Dermatol 1996 134 : 987 989.
42. Sapadin AN, Anhalt GJ. Paraneoplastic pemphigus with a pemphigus vegetans-like plaque as the only cutaneous manifestation. J Am Acad Dermatol 1998 39 : 867 871.
43. Nousari HC, Brodsky RA, Jones RJ et al. Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease. J Am Acad Dermatol 1999 40 : 750 754.
44. Williams JV, Marks JG Jr., Billingsley EM. Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus. Br J Dermatol 2000 142 : 506 508.
45. van Mook WNK, Fickers MM, Theunissen PH et al. Paraneoplastic pemphigus as the initial presentation of chronic lymphocytic leukemia. Ann Oncol 2001 12 : 115 118.
46. Powell AM, Albert S, Oyama N et al. Paraneoplastic pemphigus secondary to fludarabine evolving into unusual oral pemphigus vegetans. J Eur Acad Dermatol Venereol 2004 18 : 360 364.
47. Bronnimann M, von Felbert V, Streit M et al. Progressive respiratory failure in paraneoplastic pemphigus associated with chronic lymphocytic leukemia. Dermatology 2004 208 : 251 254.
48. Hashimoto T, Watanabe K, Ishiko A et al. A case of bullous pemphigoid with antidesmoplakin autoantibodies. Br J Dermatol 1994 131 : 694 699.
49. Jansen T, Plewig G, Anhalt GJ. Paraneoplastic pemphigus with clinical features of erosive lichen planus associated with Castleman's tumor. Dermatology 1995 190 : 245 250.
50. Lemon MA, Weston WL, Huff JC. Childhood paraneoplastic pemphigus associated with Castleman's tumour. Br J Dermatol 1997 136 : 115 117.
51. Kim SC, Chang SN, Lee IJ et al. Localized mucosal involvement and severe pulmonary involvement in a young patient with paraneoplastic pemphigus associated with Castleman's tumour. Br J Dermatol 1998 138 : 667 671.
52. Wolff H, Kunte C, Messer G et al. Paraneoplastic pemphigus with fatal pulmonary involvement in a woman with a mesenteric Castleman tumour. Br J Dermatol 1999 140 : 313 316.
53. Lee IJ, Kim SC, Kim HS et al. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma arising from Castleman's tumor. J Am Acad Dermatol 1999 40 : 294 297.
54. Irsutti M, Paul JL, Selves J et al. Castleman disease: CT and MR imaging features of a retroperitoneal location in association with paraneoplastic pemphigus. Eur Radiol 1999 9 : 1219 1221.
55. Mascaro JM Jr., Ferrando J, Sole MT et al. Paraneoplastic pemphigus: a case of long-term survival associated with systemic lupus erythematosus and polymyositis. Dermatology 1999 199 : 63 66.
56. Chorzelski T, Hashimoto T, Maciejewska B et al. Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans. J Am Acad Dermatol 1999 41 : 393 400.
57. Pan DL, Li HZ, Mao QZ. Castleman disease complicated with paraneoplastic pemphigus - a case report. Zhonghua Yi Xue Za Zhi 2005 85 : 273 275.
58. Marzano AV, Vezzoli P, Mariotti F et al. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma and Castleman disease. Br J Dermatol 2005 153 : 214 215.
59. Lane JE, Woody C, Davis LS et al. Paraneoplastic autoimmune multiorgan syndrome (paraneoplastic pemphigus) in a child: case report and review of the literature. Pediatrics 2004 114 : e513 e516.
60. Favia GF, Di Alberti L, Piattelli A. Paraneoplastic pemphigus: a report of two cases. Oral Oncol 1998 34 : 571 575.
61. Norris DL, Saywell MS, Strutton GM et al. Pemphigus vulgaris associated with spindle cell thymoma. Australas J Dermatol 1993 34 : 97 102.
62. Ishii M, Izumi J, Fujiwara H et al. Immunoblotting detection of gamma-catenin (plakoglobin) antibody in the serum of a patient with paraneoplastic pemphigus. Br J Dermatol 2001 144 : 377 9.
63. Leyn J, Degreef H. Paraneoplastic pemphigus in a patient with a thymoma. Dermatology 2001 202 : 151 154.
64. Perniciaro C, Kuechle MK, Colon-Otero G et al. Paraneoplastic pemphigus: a case of prolonged survival. Mayo Clin Proc 1994 69 : 851 855.
65. Kirsner RS, Anhalt GJ, Kerdel FA. Treatment with alpha interferon associated with the development of paraneoplastic pemphigus. Br J Dermatol 1995 132 : 474 478.
66. Becker LR, Bastian BC, Wesselmann U et al. Paraneoplastic pemphigus treated with dexamethasone/cyclophosphamide pulse therapy. Eur J Dermatol 1998 8 : 551 3.
67. Perera GK, Devereux S, Mufti G et al. PNP with Waldenstrom's macroglobulinaemia. Clin Exp Dermatol 2005 30 : 27 29.
68. Dega H, Laporte JL, Joly P et al. Paraneoplastic pemphigus associated with Hodgkin's disease. Br J Dermatol 1998 138 : 196 198.
69. Rongioletti F, Truchetet F, Rebora A. Paraneoplastic pemphigoid- pemphigus? Subepidermal bullous disease with pemphigus-like direct immunofluorescence. Int J Dermatol 1993 32 : 48 51.
70. Wong KC, Ho KK. Pemphigus with pemphigoid-like presentation, associated with squamous cell carcinoma of the tongue. Australas J Dermatol 2000 41 : 178 180.
71. Martel P, Gilbert D, Labeille B et al. A case of paraneoplastic pemphigus with antidesmoglein 1 antibodies as determined by immunoblotting. Br J Dermatol 2000 142 : 812 813.
72. Krunic AL, Kokai D, Bacetic B et al. Retroperitoneal round-cell liposarcoma associated with paraneoplastic pemphigus presenting as lichen planus pemphigoides-like eruption. Int J Dermatol 1997 36 : 526 529.
73. Seishima M, Oda M, Oyama Z et al. Antibody titers to desmogleins 1 and 3 in a patient with paraneoplastic pemphigus associated with follicular dendritic cell sarcoma. Arch Dermatol 2004 140 : 1500 1503.
74. Gironet N, De Muret A, Machet L et al. [Paraneoplastic pemphigus revealing dendritic cell sarcoma originating from Castleman's disease of the neck. Ann Dermatol Venereol 2005 132 : 41 44.
75. Schoen H, Foedinger D, Derfler K et al. Immunoapheresis in paraneoplastic pemphigus. Arch Dermatol 1998 134 : 706 10.
76. van der Waal RI, Pas HH, Nousari HC et al. Paraneoplastic pemphigus caused by an epithelioid leiomyosarcoma and associated with fatal respiratory failure. Oral Oncol 2000 36 : 390 393.
77. Berg WA, Fishman EK, Anhalt GJ. Retroperitoneal reticulum cell sarcoma: a cause of paraneoplastic pemphigus. South Med J 1993 86 : 215 217.
78. Beele H, Claerhout I, Kestelyn P et al. Bilateral corneal melting in a patient with paraneoplastic pemphigus. Dermatology 2001 202 : 147 150.
79. Santi CG, Flores RS, Medina MM et al. Paraneoplastic pemphigus associated with pelvic inflammatory fibrosarcoma: a case report. J Dermatol 2005 32 : 1014 1020.
80. Schaeppi H, Bauer JW, Hametner R et al. A localized variant of paraneoplastic pemphigus: acantholysis associated with malignant melanoma. Br J Dermatol 2001 144 : 1249 1254.
81. Ashinoff R, Cohen R, Lipkin G. Castleman's tumor and erosive lichen planus: coincidence or association? Report of a case. J Am Acad Dermatol 1989 21 : 1076 1080.
82. Anhalt GJ. Paraneoplastic pemphigus. Adv Dermatol 1997 12 : 77 96 discussion 7.
83. Chan LS. Epitope spreading in paraneoplastic pemphigus: autoimmune induction in antibody-mediated blistering skin diseases. Arch Dermatol 2000 136 : 663 664.
84. Wang J, Bu DF, Zhu XJ. Immunoglobulin variable region gene rearrangement and hypermutation in paraneoplastic pemphigus associated Castleman's tumor. Beijing Da Xue Xue Bao 2004 36 : 454 461.
85. Wang J, Zhu XJ. The new development on pathogenesis of autoimmune paraneoplastic pemphigus. Beijing Da Xue Xue Bao 2004 36 : 540 3.
86. Pizarro A, Garcia-Tobaruela A, Pinilla J. Bronchiolitis obliterans, Castleman's disease, and a bullous disease: pemphigus vulgaris or paraneoplastic pemphigus? Hum Pathol 1998 29 : 657 658.
87. Hoffman MA, Qiao X, Anhalt GJ. CD8+ T lymphocytes in bronchiolitis obliterans, paraneoplastic pemphigus, and solitary Castleman's disease. N Engl J Med 2003 349 : 407 408.
88. Radzikowska E, Pawlowski J, Chabowski M et al. Constrictive bronchiolitis obliterans in patient with Castelman's disease. Monaldi Arch Chest Dis 2005 63 : 226 229.
89. Saito K, Morita M, Enomoto K. Bronchiolitis obliterans with pemphigus vulgaris and Castleman's disease of hyaline-vascular type: an autopsy case analyzed by computer-aided 3-D reconstruction of the airway lesions. Hum Pathol 1997 28 : 1310 1312.
90. Mar WA, Glaesser R, Struble K et al. Paraneoplastic pemphigus with bronchiolitis obliterans in a child. Pediatr Dermatol 2003 20 : 238 242.
91. Mydlarski PR, Mittmann N, Shear NH. In travenous immunoglobulin: use in dermatology. Skin Ther Lett 2004 9 : 1 6.
92. Gelfand EW. Use of IGIV in the treatment of immune-mediated dermatologic disorders. J Investig Dermatol Symp Proc 2004 9 : 92 96.
93. Jolles S, Hughes J, Whittaker S. Dermatological uses of high-dose intravenous immunoglobulin. Arch Dermatol 1998 134 : 80 86.